Rob Maloney: Over 104,000 USD Raised at The 2026 Trot to Clot
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”On May 16th, a small community did something remarkable.
Over 104,000 USD raised at the 2026 Trot to Clot.
I’ve said it before and I mean it every time.
It’s the big actions of a small community that make this work possible.
Every dollar raised goes toward our global impact program.
People living with bleeding disorders in underserved communities around the world who don’t have what our patients in Georgia have.
Access, support, a team that knows their name.
That gap is real. And events like this help close it.
To our sponsors, thank you. You make the starting line possible.
To our team captains, fundraisers, runners, walkers, volunteers, and donors.
You showed up. That matters more than you know.
This community never stops surprising me.
If you couldn’t make it this year but want to be part of what we’re building globally, there’s still a way in.
See you at the finish line next year.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas LangÖ‰ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge